Standout Papers

The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Tri... 2019 2026 2021 2023 243
  1. The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials (2019)
    Arun J. Sanyal, Stephen A. Harrison et al. Hepatology

Immediate Impact

1 by Nobel laureates 61 standout
Sub-graph 1 of 17

Citing Papers

New and emerging treatments for metabolic dysfunction-associated steatohepatitis
2024 Standout
Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis
2024 Standout
12 intermediate papers

Works of Catherine Jia being referenced

Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis
2021
The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials
2019 Standout
and 3 more

Author Peers

Author Last Decade Papers Cites
Catherine Jia 405 86 45 315 133 24 701
L. A. Rybicki 429 104 37 259 114 19 740
Hiroaki Hazama 338 22 5 240 134 19 686
Yang‐Gun Suh 166 49 39 176 156 38 711
Anna Verrone 366 16 9 112 101 32 721
John Frye 100 33 46 148 284 24 744
S Seto 171 52 189 156 204 20 758
Milind Ronghe 56 38 60 162 163 23 581
Andrew Scanga 286 7 16 376 62 19 659
H Kalbfleisch 180 20 15 116 90 31 721
Motonobu Watanabe 294 93 33 382 81 22 778

All Works

Loading papers...

Rankless by CCL
2026